Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

NorthStar Gaming to Host Q2 2025 Earnings Webinar...

August 8, 2025

Osisko Metals Intersects 731 Metres Averaging 0.29% Cu...

August 13, 2025

Crypto Market Review: Trump Media Planning US$3 Billion...

May 27, 2025

Crypto Market Update: Ethereum Rallies Past US$4,000, Trump...

August 9, 2025

Locksley Resources LimitedStrengthens US Defence Supply Chain Strategy...

November 24, 2025

Settlement of Tranche 1 Share Placement

June 26, 2025

New Found Gold

December 24, 2025

JZR Gold Inc. Announces Completion of Testing of...

May 14, 2025

Prismo Metals Discovers Two Separate Mineralized Veins at...

August 28, 2025

High-Grade Uranium from drilling at Oasis

September 4, 2025